Soleno Therapeutics: Rare Disease Pick With Significant Potential And Low Valuation [Seeking Alpha]
Soleno Therapeutics, Inc. (SLNO)
Last soleno therapeutics, inc. earnings: 5/13 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.soleno.life/investor-overview
Company Research
Source: Seeking Alpha
Soleno Therapeutics: Rare Disease Pick With Significant Potential And Low ValuationSummaryThe stock has risen by nearly 40% year to date and is currently sitting on support.Lead program DCCR appears significantly derisked due to encouraging data from an open-label study and decades of prior use for diazoxide free base.The current phase 3 study should take 9 to 12 months to complete and details of the design plus endpoints have been agreed upon with the FDA.The rare disease known as Prader-Willi syndrome has no approved treatments and an addressable patient population of 20,000 in the US.Management is pursuing a broad IP strategy and other conditions could be addressed after PWS. I suggest initiating a pilot position and accumulating dips.
Show less
Read more
Impact Snapshot
Event Time:
SLNO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLNO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLNO alerts
High impacting Soleno Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SLNO
News
- INVESTIGATION ALERT: Kaskela Law LLC Announces Shareholder Investigation of Soleno Therapeutics, Inc. (SLNO) and Encourages Investors to Contact the FirmAccesswire
- Soleno Therapeutics, Inc. (NASDAQ: SLNO) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $72.00 price target on the stock.MarketBeat
- Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsGlobeNewswire
- While institutions invested in Soleno Therapeutics, Inc. (NASDAQ:SLNO) benefited from last week's 4.8% gain, private equity firms stood to gain the most [Yahoo! Finance]Yahoo! Finance
SLNO
Earnings
- 5/9/24 - Miss
SLNO
Sec Filings
- 5/10/24 - Form 8-K
- 5/9/24 - Form 10-Q
- 5/7/24 - Form 8-K
- SLNO's page on the SEC website